15th Annual Heart Failure Holiday Symposium

Thursday, December 5, 2019, 6:00 PM - Saturday, December 7, 2019, 5:30 PM, Radisson Blu Chicago


The purpose of this event is to share advances in heart failure prevention and biomarkers. In addition, to assemble some of the best leading cardiologists, cardiac surgeons, nurses, and psychologists to provide updates on the very latest clinical, scientific, genetic, behavioral and technological advances.

1. Review pertinent new findings targeting the prevention of heart failure.
2. Describe the evaluation and treatment approach to various cardiomyopathies including those which are heritable.
3. Describe the current state of cardiac amyloidosis with an emphasis on emerging, novel therapeutic agents.
4. Identify the key differences and approaches used in managing different heart failure syndromes including those with preserved, reduced, and recovered ejection fraction.
5. Describe the current state of genetics and genetic testing in the evaluation of the heart failure patient with dilated cardiomyopathy.
6. Summarize the state of advanced heart failure including the evolution of mechanical support devices for the treatment of end stage heart failure.
7. Describe the current state of pulmonary hypertension treatments including the emergence of percutaneous, interventional treatment strategies.
8. Identify the approach to developing a multidisciplinary heart failure program with an emphasis on optimizing transitions of care and reducing hospital readmissions.
9. Explain the pros and cons to the current heart failure reduction readmission program including potential unintended consequences.
10. Explore the various surgical and interventional therapies for heart failure including in those with valvular heart disease and cardiogenic shock.
11. Describe risk factors for poor heart failure self-care, new approaches to patient and caregiver education, psychosocial challenges of heart failure, and age-related factors in candidacy for advanced surgical therapies.
12. Describe intricacies of shared decision making for heart failure patients considering advanced surgical therapies and the role of palliative care in heart failure management.

Early Bird Rate (Ends on Friday, November 15, 2019 at 5:00 PM)

• Physicians $475
• Industry Professionals $475
• Nurses/Other HCP $325
• Northwestern Medicine Physicians, Nurses and Staff $250

Full Rate

• Physicians $575
• Industry Professionals $575
• Nurses/Other HCP $385
• Northwestern Medicine Physicians, Nurses and Staff $475
• Fellows/Residents/Trainees*/Landsberg Society Members $250

*Trainees must submit Program Director's letter to [email protected].

Cancellation Policy

Cancellations must be made in writing to [email protected] . The paid registration fee, minus a $50 administrative charge, will be refunded if cancellation is received by October 31, 2019. No refunds will be issued after this date.

Online registration will close on December 3, 2019 at 12:00 PM. 
Onsite registration will be available via cash or check only.

The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 10.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 Credits™ (12.25 hours), Non-Physician Attendance (12.25 hours)